IRLAB Therapeutics AB Class A's market cap is currently €231.46M. The company's EPS TTM is kr-0.623; its P/E ratio is ―; IRLAB Therapeutics AB Class A is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
IRLAB Therapeutics AB Class A Earnings and Revenue History
